| Nuchal translucency measurement in an unselected population: Screening for fetal chromosomal abnormalities and structural defects | Cem BATUKAN,Hayri ERMİŞ,Recep HAS,Atıl YÜKSEL,Melike BATUKAN,İbrahim KALELİOĞLU,Sevgi TERCANLI | 166–172 |
| The significance of Doppler flow characteristics and serum fibronectin level in preeclampsia | İlknur SEVİNÇLİ,Hakan KANIT,Azra ARICI,Çiğdem İSPAHİ | 173–177 |
| Red blood cell superoxide dismutase levels in preeclamptic patients and their fetuses | Önder ÇELİK,Şeyma HASÇALIK,Aysun BAY | 178–180 |
| Maternal inhibin-A levels are not useful in prediction of late onset preeclampsia in low risk group: A longitudinal study | Bülent ÖZÇELİK,İ. Serdar SERİN,Mustafa BAŞBUĞ,Derya OKUR,Sebahattin MUHTAROĞLU,MEHMET TAYYAR | 181–184 |
| The changing pattern of eclampsia over a 15-year period at a university hospital | İbrahin Serdar SERİN,Bülent ÖZÇELİK,Mustafa BAŞBUĞ,MEHMET TAYYAR | 185–188 |
| Does ritodrine infusion have any effects on umbilical and uterine arteries' blood flows during the treatment of preterm labor | Zeki ŞAHİNOĞLU,Ayşe GÜRBÜZ,Özhan AKKAN,Ateş KARATEKE | 189–193 |
| Is gestional week at cerclage influential on the efficacy of the procedure: A review of 210 cases | Azra ARICI,Muzaffer SANCI,Seda ÖZKİRİŞÇİ,Ahmet GÜLER,Çiğdem İSPAHİ | 194–198 |
| Deep venous thrombosis in Turkish pregnant women | Mehmet GÖKÇÜ,F. Suat DEDE,İlhan ARSLANPENÇE,Tarık DEMİRDAĞ,Orhan GELİŞEN | 199–201 |
| Incidence of neonatal care unit admission after preterm delivery between 34 and 36 weeks gestation | Yaprak ENGİN,Yusuf ÜSTÜN,Müge AKSOY,Cem ATABEKOĞLU,Acar KOÇ,Begüm ATASAY | 202–204 |
| Lamellar body counts in amniotic fluid and the relation with Dubowitz scoring sysytems | Önder ÇELİK,Şeyma HASÇALIK,Gönül KAZEZOĞLU | 205–207 |
| Preeclampsia and calciuria | Ali Sami GÜRBÜZ,İLKER GÜNYELİ,Rüya DEVEER,Nuri DANIŞMAN | 208–210 |
| The inactivating point mutation (566C-->T) in the follicle-stimulating hormone receptor gene in Turkish women with polycystic ovary syndrome |